GCG and diabetes mellitus: A related study, also employing Ins1CRE/+;Rosa26-eYFP transgenic mice, recently examined the positive impact of clinically approved incretin enhancers, liraglutide and sitagliptin, on islet cell lineage in diabetes [10].